# Treatment Trial of Alveolar Echinococcosis

> **NCT07182305** · PHASE2 · COMPLETED · sponsor: **Ministry of Health, Kyrgyzstan** · enrollment: 194 (actual)

## Conditions studied

- Alveolar Echinococcosis

## Interventions

- **DRUG:** Efficacy of albendazole for early stage intervention of alveolar echinococcosis

## Key facts

- **NCT ID:** NCT07182305
- **Lead sponsor:** Ministry of Health, Kyrgyzstan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2021-04-30
- **Final completion:** 2023-07-31
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2025-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07182305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07182305, "Treatment Trial of Alveolar Echinococcosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07182305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*